HIV Diversity and Classification, Role in Transmission


The hallmark of HIV-1 is its extensive genetic diversity that emanates mainly from high mutations. Phylogenetically, HIV can be classified into geographically confined groups, types, subtypes and circulating recombinant forms (CRFs) that are however subject to change over time. HIV genetic diversity may partially explain the observed heterogeneity in HIV prevalence and has also been reported to impact on viral transmissibility and differential rates of disease progression. The aim of this review is to present a simple overview of the principles and concepts of HIV diversity and classification. Tracking the presence of new HIV strains is not only important for surveillance purposes but is also critical in facilitating personalized targeted therapy as well as forming the basis for development of the much anticipated effective vaccines against this scourge.

Share and Cite:

D. Kerina, S. Babill and F. Muller, "HIV Diversity and Classification, Role in Transmission," Advances in Infectious Diseases, Vol. 3 No. 2, 2013, pp. 146-156. doi: 10.4236/aid.2013.32022.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] R. M. Lynch, T. Shen, S. Gnanakaran and C. A. Derdeyn, “Appreciating HIV Type 1 Diversity: subtype Differences in Env,” AIDS Research and Human Retroviruses, Vol. 25, No. 3, 2009, pp. 237-248. doi:10.1089/aid.2008.0219
[2] F. McCutchan, E. K. Viputtigul, M. S. de Souza, J. K. Carr, L. E. Markowitz, P. Buapunth, et al., “Diversity of Envelope Glycoprotein from Human Immunodeficiency Virus Type 1 of Recent Seroconverters in Thailand,” AIDS Research and Human Retroviruses, Vol. 16, No. 8, 2000, pp. 801-805. doi:10.1089/088922200308792
[3] F. E. McCutchan, A. W. Artenstein, E. Sanders-Buell, M. O. Salminen, J. K. Carr, J. R. Mascola, et al., “Diversity of the Envelope Glycoprotein among Human Immunodeficiency Virus Type 1 Isolates of Clade E from Asia and Africa,” Journal of Virology, Vol. 70, No. 6, 1996, pp. 3331-3338.
[4] F. E. McCutchan, M. O. Salminen, J. K. Carr and D. S. Burke, “HIV-1 Genetic Diversity,” AIDS, Vol. 10, Suppl. 3, 1996, pp. S13-S20. doi:10.1097/00002030-199601001-00003
[5] D. Almond, T. Kimura, X. Kong, J. Swetnam, S. Zolla-Pazner and T. Cardozo, “Structural Conservation Predominates over Sequence Variability in the Crown of HIV Type 1’s V3 Loop,” AIDS Research and Human Retroviruses, Vol. 26, No. 6, 2010, pp. 717-723. doi:10.1089/aid.2009.0254
[6] J. M. Mercado, D. R. Di and M. G. Pradal, “Genetic Diversity of HIV-1 Subtype F from Brazil: Failure of HIV-1 Viral Load Testing Based on Molecular Biology Amplification Methods,” AIDS, Vol. 1, No. 15, 1999, pp. 2183-2185. doi:10.1097/00002030-199910220-00032
[7] B. G. Brenner, M. Oliveira, F. Doualla-Bell, D. D. Moisi, M. Ntemgwa, F. Frankel, et al., “HIV-1 Subtype C Viruses Rapidly Develop K65R Resistance to Tenofovir in Cell Culture,” AIDS, Vol. 20, No. 9, 2006, pp. F9-F13. doi:10.1097/01.aids.0000232228.88511.0b
[8] J. P. Clewley, “Genetic Diversity and HIV Detection by PCR,” Lancet, Vol. 346, No. 8988, 1995, p. 1489. doi:10.1016/S0140-6736(95)92505-8
[9] “Diversity of HIV Strains Impacts Diagnostic Test Accuracy,” AIDS Patient Care STDS, Vol. 23, No. 3, 2009, p. 220.
[10] C. Apetrei, I. Loussert-Ajaka, D. Descamps, F. Damond, S. Saragosti, F. Brun-Vezinet, et al., “Lack of Screening Test Sensitivity during HIV-1 Non-Subtype B Seroconversions,” AIDS, Vol. 10, No. 14, 1996, pp. F57-F60. doi:10.1097/00002030-199612000-00002
[11] M. S. Cohen, C. L. Gay, M. P. Busch and F. M. Hecht, “The Detection of Acute HIV Infection,” The Journal of Infectious Diseases, Vol. 202, Suppl. 2, 2010, pp. S270-S277. doi:10.1086/655651
[12] H. Bolivar, R. Geffin, G. Manzi, M. A. Fischl, V. Holzmayer, W. B. Mak, et al., “The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected with a Subtype F Strain,” Journal of Acquired Immune Deficiency Syndromes, Vol. 52, No. 5, 2009, pp. 659-661. doi:10.1097/QAI.0b013e3181b72539
[13] B. Julg and F. D. Goebel, “HIV Genetic Diversity: Any Implications for Drug Resistance?” Infection, Vol. 33, No. 4, 2005, pp. 299-301. doi:10.1007/s15010-005-6405-1
[14] S. Spira, M. A. Wainberg, H. Loemba, D. Turner and B. G. Brenner, “Impact of Clade Diversity on HIV-1 Virulence, Antiretroviral Drug Sensitivity and Drug Resistance,” Journal of Antimicrobial Chemotherapy, Vol. 51, No. 2, 2003, pp. 229-240. doi:10.1093/jac/dkg079
[15] C. T. Edwards, E. C. Holmes, D. J. Wilson, R. P. Viscidi, E. J. Abrams, R. E. Phillips, et al., “Population Genetic Estimation of the Loss of Genetic Diversity during Horizontal Transmission of HIV-1,” BMC Evolutionary Biology, Vol. 6, 2006, p. 28. doi:10.1186/1471-2148-6-28
[16] A. Lange and N. M. Ferguson, “Antigenic Diversity, Transmission Mechanisms, and the Evolution of Pathogens,” PLOS Computational Biology, Vol. 5, No. 10, 2009, Article ID: e1000536. doi:10.1371/journal.pcbi.1000536
[17] M. A. Papathanasopoulos, G. M. Hunt and C. T. Tiemessen, “Evolution and Diversity of HIV-1 in Africa—A Review,” Virus Genes, Vol. 26, No. 2, 2003, pp. 151-163. doi:10.1023/A:1023435429841
[18] D. M. Tebit, I. Nankya, E. J. Arts and Y. Gao, “HIV Diversity, Recombination and Disease Progression: How Does Fitness ‘Fit’ into the Puzzle?” AIDS Reviews, Vol. 9, No. 2, 2007, pp. 75-87.
[19] H. Zhang, D. C. Tully, F. G. Hoffmann, J .He, C. Kankasa and C. Wood, “Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants,” PLoS One, Vol. 5, No. 2, 2010, Article ID: e9294. doi:10.1371/journal.pone.0009294
[20] M. S. Saag, S. M. Hammer and J. M. Lange, “Pathogenicity and Diversity of HIV and Implications for Clinical Management: A Review,” Journal of Acquired Immune Deficiency Syndromes, Vol. 7, Suppl. 2, 1994, pp. S2-S10.
[21] R. B. Lal, S. Chakrabarti and C. Yang, “Impact of Genetic Diversity of HIV-1 on Diagnosis, Antiretroviral Therapy & Vaccine Development,” Indian Journal of Medical Research, Vol. 121, No. 4, 2005, 287-314.
[22] S. Bonhoeffer, E. C. Holmes and M. A. Nowak, “Causes of HIV Diversity,” Nature, Vol. 376, No. 6536, 1995, p. 125. doi:10.1038/376125a0
[23] Y. Takebe, “HIV-1 Genetic Diversity: Mechanism and Its Biological Implication,” Uirusu, Vol. 51, No. 2, 2001, pp. 123-134. doi:10.2222/jsv.51.123
[24] R. B. Oelrichs, I. L. Shrestha, D. A. Anderson and N. J. Deacon, “The Explosive Human Immunodeficiency Virus Type 1 Epidemic among Injecting Drug Users of Kathmandu, Nepal, Is Caused by a Subtype C Virus of Restricted Genetic Diversity,” Journal of Virology, Vol. 74, No. 3, 2000, pp. 1149-1157. doi:10.1128/JVI.74.3.1149-1157.2000
[25] D. Shriner, A. G. Rodrigo, D. C. Nickle and J. I. Mullins, “Pervasive Genomic Recombination of HIV-1 in Vivo,” Genetics, Vol. 167, No. 4, 2004, pp. 1573-1583. doi:10.1534/genetics.103.023382
[26] G. Fang, B. Weiser, C. Kuiken, S. M. Philpott, S. Rowland-Jones, F. Plummer, et al., “Recombination Following Superinfection by HIV-1,” AIDS, Vol. 18, No. 2, 2004, pp. 153-159. doi:10.1097/00002030-200401230-00003
[27] A. Machuca, S. Tang, J. Hu, S. Lee, O. Wood, C. Vockley, et al., “Increased Genetic Diversity and Intersubtype Recombinants of HIV-1 in Blood Donors from Urban Cameroon,” Journal of Acquired Immune Deficiency Syndromes, Vol. 45, No. 3, 2007, pp. 361-363. doi:10.1097/QAI.0b013e318053754c
[28] N. N. Vijay, Vasantika, R. Ajmani, A. S. Perelson and N. M. Dixit, “Recombination Increases Human Immunodeficiency Virus Fitness, but Not Necessarily Diversity,” Journal of General Virology, Vol. 89, Pt. 6, 2008, pp. 1467-1477. doi:10.1099/vir.0.83668-0
[29] K. Delviks-Frankenberry, A. Galli, O. Nikolaitchik, H. Mens, V. K. Pathak and W. S. Hu, “Mechanisms and Factors That Influence High Frequency Retroviral Recombination,” Viruses, Vol. 3, No. 9, 2011, pp. 1650-1680. doi:10.3390/v3091650
[30] A. C. van der Kuyl and M. Cornelissen, “Identifying HIV-1 Dual Infections,” Retrovirology, Vol. 4, 2007, p. 67. doi:10.1186/1742-4690-4-67
[31] A. R. Templeton, M. G. Kramer, J. Jarvis, J. Kowalski, S. Gange, M. F. Schneider, et al., “Multiple-Infection and Recombination in HIV-1 within a Longitudinal Cohort of Women,” Retrovirology, Vol. 6, 2009, p. 54. doi:10.1186/1742-4690-6-54
[32] B. Chohan, L. Lavreys, S. M. Rainwater and J. Overbaugh, “Evidence for Frequent Reinfection with Human Immunodeficiency Virus Type 1 of a Different Subtype,” Journal of Virology, Vol. 79, No. 16, 2005, pp. 10701-10708. doi:10.1128/JVI.79.16.10701-10708.2005
[33] D. J. Hu, S. Subbarao, S. Vanichseni, P. A. Mock, A. Ramos, L. Nguyen, et al., “Frequency of HIV-1 Dual Subtype Infections, including Intersubtype Superinfections, among Injection Drug Users in Bangkok, Thailand,” AIDS, Vol. 19, No. 3, 2005, pp. 303-308.
[34] F. E. McCutchan, M. Hoelscher, S. Tovanabutra, S. Piyasirisilp, E. Sanders-Buell, G. Ramos, et al., “In-Depth Analysis of a Heterosexually Acquired Human Immunodeficiency Virus Type 1 Superinfection: Evolution, Temporal Fluctuation, and Intercompartment Dynamics from the Seronegative Window Period through 30 Months Postinfection,” Journal of Virology, Vol. 79, No. 18, 2005, pp. 11693-11704. doi:10.1128/JVI.79.18.11693-11704.2005
[35] K. L. Gross, T. C. Porco and R. M. Grant, “HIV-1 Superinfection and Viral Diversity,” AIDS, Vol. 18, No. 11, 2004, pp. 1513-1520. doi:10.1097/01.aids.0000131361.75328.47
[36] J. C. Plantier, V. Lemee, I. Dorval, M. Gueudin, J. Braun, P. Hutin, et al., “HIV-1 Group M Superinfection in an HIV-1 Group O-Infected Patient,” AIDS, Vol. 18, No. 18, 2004, pp. 2444-2446.
[37] G. S. Gottlieb, D. C. Nickle, M. A. Jensen, K. G. Wong, J. Grobler, F. Li, et al., “Dual HIV-1 Infection Associated with Rapid Disease Progression,” The Lancet, Vol. 363, No. 9409, 2004, pp. 619-622. doi:10.1016/S0140-6736(04)15596-7
[38] T. M. Allen and M. Altfeld, “HIV-1 Superinfection,” The Journal of Allergy and Clinical Immunology, Vol. 112, No. 5, 2003, pp. 829-835. doi:10.1016/j.jaci.2003.08.037
[39] J. Grobler, C. M. Gray, C. Rademeyer, C. Seoighe, G. Ramjee, S. A. Karim, et al., “Incidence of HIV-1 Dual Infection and Its Association with Increased Viral Load Set Point in a Cohort of HIV-1 Subtype C-Infected Female Sex Workers,” The Journal of Infectious Diseases, Vol. 190, No. 7, 2004, pp. 1355-1359. doi:10.1086/423940
[40] E. Saathoff, M. Pritsch, C. Geldmacher, O. Hoffmann, R. N. Koehler, L. Maboko, et al., “Viral and Host Factors Associated with the HIV-1 Viral Load Setpoint in Adults from Mbeya Region, Tanzania,” Journal of Acquired Immune Deficiency Syndromes, Vol. 54, No. 3, 2010, pp. 324-330. doi:10.1097/QAI.0b013e3181cf30ba
[41] B. H. Chohan, A. Piantadosi and J. Overbaugh, “HIV-1 Superinfection and Its Implications for Vaccine Design,” Current HIV Research, Vol. 8, No. 8, 2010, pp. 596-601. doi:10.2174/157016210794088218
[42] D. D. Ho, A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard and M. Markowitz, “Rapid Turnover of Plasma Virions and CD4 Lymphocytes in HIV-1 Infection,” Nature, Vol. 373, No. 6510, 1995, pp. 123-126. doi:10.1038/373123a0
[43] J. Zhang, “Host RNA Polymerase II Makes Minimal Contributions to Retroviral Frame Shift Mutations,” Journal of General Virology, Vol. 85, No. 8, 2004, pp. 2389-2395. doi:10.1099/vir.0.80081-0
[44] J. Eberle and L. Gurtler, “HIV Types, Groups, Subtypes and Recombinant Forms: Errors in Replication, Selection Pressure and Quasispecies,” Intervirology, Vol. 55, No. 2, 2012, pp. 79-83. doi:10.1159/000331993
[45] P. Jern, R. A. Russell, V. K. Pathak and J. M. Coffin, “Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance,” PloS Pathogens, Vol. 5, No. 4, 2009, e100367. doi:10.1371/journal.ppat.1000367
[46] R. Sampathkumar, E. Shadabi and M. Luo, “Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response,” Advances in Virology, Vol. 2012, No. 2012, 2012, Article ID: 508967.
[47] C. Brander, N. Frahm and B. D. Walker, “The Challenges of Host and Viral Diversity in HIV Vaccine Design,” Current Opinion in Immunology, Vol. 18, No. 4, 2006, pp. 430-437. doi:10.1016/j.coi.2006.05.012
[48] B. F. Keele, L. Tazi, S. Gartner, Y. Liu, T. B. Burgon, J. D. Estes, et al., “Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1,” Journal of Virology, Vol. 82, No. 11, 2008, pp. 5548-5561. doi:10.1128/JVI.00124-08
[49] C. Kuiken, R. Thakallapalli, A. Esklid and R. de Anthony, “Genetic Analysis Reveals Epidemiologic Patterns in the Spread of Human Immunodeficiency Virus,” American Journal of Epidemiology, Vol. 152, No. 9, 2000, pp. 814-822. doi:10.1093/aje/152.9.814
[50] S. Wain-Hobson and G. Myers, “Human Immunodeficiency Viruses. Too Close for Comfort,” Nature, Vol. 347, No. 6288, 1990, p. 18.
[51] J. L. Sankale, R. S. De La Tour, R. G. Marlink, R. Scheib, S. Mboup, M. E. Essex, et al., “Distinct Quasi-Species in the Blood and the Brain of an HIV-2-Infected Individual,” Virology, Vol. 226, No. 2, 1996, pp. 418-423. doi:10.1006/viro.1996.0671
[52] M. Goodenow, T. Huet, W. Saurin, S. Kwok, J. Sninsky and S. Wain-Hobson, “HIV-1 Isolates Are Rapidly Evolving Quasispecies: Evidence for Viral Mixtures and Preferred Nucleotide Substitutions,” Journal of Acquired Immune Deficiency Syndromes, Vol. 2, No. 4, 1989, pp. 344-352.
[53] A. S. Lauring and R. Andino, “Quasispecies Theory and the Behavior of RNA Viruses,” PLoS Pathogens, Vol. 6, No. 7, 2010, e1001005. doi:10.1371/journal.ppat.1001005
[54] M. M. Jackson, S. R. Stanley, P. Nelson, D. R. Richardson and G. B. White, “Compendium of HIV/AIDS Positions, Policies and Documents,” American Nurses Association Publications, Silver Spring, 1992.
[55] J. Louwagie, W. Janssens, J. Mascola, L. Heyndrickx, P. Hegerich, G. van der Groen, et al., “Genetic Diversity of the Envelope Glycoprotein from Human Immunodeficiency Virus Type 1 Isolates of African Origin,” Journal of Virology, Vol. 69, No. 1, 1995, pp. 263-271.
[56] A. Abebe, G. Pollakis, A. L. Fontanet, B. Fisseha, B. Tegbaru, A. Kliphuis, et al., “Identification of a Genetic Subcluster of HIV Type 1 Subtype C (C') Widespread in Ethiopia,” AIDS Research and Human Retroviruses, Vol. 16, No. 17, 2000, pp. 1909-1914. doi:10.1089/08892220050195865
[57] J. Archer and D. L. Robertson, “Understanding the Diversification of HIV-1 Groups M and O,” AIDS, Vol. 21, No. 13, 2007, pp. 1693-1700. doi:10.1097/QAD.0b013e32825eabd0
[58] P. C. Aulicino, J. Kopka, A. M. Mangano, C. Rocco, M. Iacono, R. Bologna, et al., “Circulation of Novel HIV Type 1 A, B/C, and F Subtypes in Argentina,” AIDS Research and Human Retroviruses, Vol. 21, No. 2, 2005, pp. 158-164. doi:10.1089/aid.2005.21.158
[59] I. Bartolo, C. Rocha, J. Bartolomeu, A. Gama, R. Marcelino, M. Fonseca, et al., “Highly Divergent Sub-types and New Recombinant Forms Prevail in the HIV/AIDS Epidemic in Angola: New Insights into the Origins of the AIDS Pandemic,” Infection, Genetics and Evolution, Vol. 9, No. 4, 2009, pp. 672-682. doi:10.1016/j.meegid.2008.05.003
[60] H. Bredell, G. Hunt, A. Casteling, T. Cilliers, C. Rademeyer, M. Coetzer, et al., “HIV-1 Subtype A, D, G, AG and Unclassified Sequences Identified in South Africa,” AIDS Research and Human Retroviruses, Vol. 18, No. 9, 2002, pp. 681-683. doi:10.1089/088922202760019400
[61] F. Gao, L. Yue, D. L. Robertson, S. C. Hill, H. Hui, R. J. Biggar, et al., “Genetic Diversity of Human Immunodeficiency Virus Type 2: Evidence for Distinct Sequence Subtypes with Differences in Virus Biology,” Journal of Virology, Vol. 68, No. 11, 1994, pp. 7433-7447.
[62] A. M. Geretti, “HIV-1 Subtypes: Epidemiology and Significance for HIV Management,” Current Opinion in Infectious Diseases, Vol. 19, No. 1, 2006, pp. 1-7. doi:10.1097/01.qco.0000200293.45532.68
[63] R. S. Diaz, L. Zhang, M. P. Busch, J. W. Mosley and A. Mayer, “Divergence of HIV-1 Quasispecies in an Epidemiologic Cluster,” AIDS, Vol. 11, No. 4, 1997, pp. 415-422. doi:10.1097/00002030-199704000-00003
[64] K. Gould, “Infection with HIV-1 Group O,” AIDS Patient Care STDs, Vol. 11, No. 6, 1997, pp. 399-405. doi:10.1089/apc.1997.11.399
[65] P. J. Kanki, M. Peeters and A. Gueye-Ndiaye, “Virology of HIV-1 and HIV-2: Implications for Africa,” AIDS, Vol. 11, Suppl B, 1997, pp. S33-S42.
[66] M. A. Pando, L. M. Eyzaguirre, M. Segura, C. T. Bautista, R. Marone, A. Ceballos, et al., “First Report of an HIV-1 Triple Recombinant of Subtypes B, C and F in Buenos Aires, Argentina,” Retrovirology, Vol. 3, 2006, p. 59. doi:10.1186/1742-4690-3-59
[67] B. C. Ramirez, E. Simon-Loriere, R. Galetto and M. Negroin, “Implications of Recombination for HIV Diversity,” Virus Research, Vol. 134, No. 1-2, 2008, pp. 64-73. doi:10.1016/j.virusres.2008.01.007
[68] J. Stebbing and G. Moyle, “The Clades of HIV: Their Origins and Clinical Significance,” AIDS Reviews, Vol. 5, No. 4, 2003, pp. 205-213.
[69] F. E. McCutchan, K. Viputtigul, M. S. de Souza, J. K. Carr, L. E. Markowitz, P. Buapunth, et al., “Diversity of Envelope Glycoprotein from Human Immunodeficiency Virus Type 1 of Recent Seroconverters in Thailand,” AIDS Research and Human Retroviruses, Vol. 16, No. 8, 2000, pp. 801-805. doi:10.1089/088922200308792
[70] F. Gao, E. Bailes, D. L. Robertson, Y. Chen, C. M. Rodenburg, S. F. Michael, et al., “Origin of HIV-1 in the Chimpanzee Pan Troglodytes Troglodytes,” Nature, Vol. 397, No. 6718, 1999, pp. 436-441.
[71] B. H. Hahn, G. M. Shaw, K. M. De Cock and P. M. Sharp, “AIDS as a Zoonosis: Scientific and Public Health Implications,” Science, Vol. 287, No. 5453, 2000, pp. 607-614. doi:10.1126/science.287.5453.607
[72] B. F. Keele, H. F. Van, Y. Li, E. Bailes, J. Takehisa, M. L. Santiago, et al., “Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1,” Science, Vol. 313, No. 5786, 2006, pp. 523-526. doi:10.1126/science.1126531
[73] V. M. Hirsch, R. A. Olmsted, M. Murphey-Corb, R. H. Purcell and P. R. Johnson, “An African Primate Lentivirus (SIVsm) Closely Related to HIV-2,” Nature, Vol. 339, No. 6223, 1989, pp. 389-392. doi:10.1038/339389a0
[74] P. R. Johnson, M. Gravell, J. Allan, S. Goldstein, R. A. Olmsted, G. Dapolito, et al., “Genetic Diversity among Simian Immunodeficiency Virus Isolates from African Green Monkeys,” Journal of Medical Primatology, Vol. 18, No. 3-4, 1989, pp. 271-277.
[75] P. M. Sharp and B. H. Hahn, “Origins of HIV and the AIDS Pandemic,” Cold Spring Harbor Perspectives in Medicine, Vol. 1, No. 1, 2011, Article ID: A006841. doi:10.1101/cshperspect.a006841
[76] F. Clavel, M. Guyader, D. Guetard, M. Salle, L. Montagnier and M. Alizon, “Molecular Cloning and Polymorphism of the Human Immune Deficiency Virus Type 2,” Nature, Vol. 324, No. 6098, 1986, pp. 691-695. doi:10.1038/324691a0
[77] P. J. Kanki, K. U. Travers, S. Mboup, C. C. Hsieh, R. G. Marlink, A. Gueye-Ndiaye, et al., “Slower Heterosexual Spread of HIV-2 than HIV-1,” The Lancet, Vol. 343, No. 8903, 1994, pp. 943-946. doi:10.1016/S0140-6736(94)90065-5
[78] R. Marlink, P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, et al., “Reduced Rate of Disease Development after HIV-2 Infection as Compared to HIV-1,” Science, Vol. 265, No. 5178, 1994, pp. 1587-1590. doi:10.1126/science.7915856
[79] C. A. Adje-Toure, R. Cheingsong, J. G. Garcia-Lerma, S. Eholie, M. Y. Borget, J. M. Bouchez, et al., “Antiretroviral Therapy in HIV-2-Infected Patients: Changes in Plasma Viral Load, CD4+ Cell Counts, and Drug Resistance Profiles of Patients Treated in Abidjan, Cote d'Ivoire,” AIDS, Vol. 17, Suppl. 3, 2003, pp. S49-S54. doi:10.1097/00002030-200317003-00007
[80] K. Motomura, J. Chen and W. S. Hu, “Genetic Recombination between Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2, Two Distinct Human Lentiviruses,” Journal of Virology, Vol. 82, No. 4, 2008, pp. 1923-1933. doi:10.1128/JVI.01937-07
[81] S. Locatelli and M. Peeters, “Cross-Species Transmission of Simian Retroviruses: How and Why They Could Lead to the Emergence of New Diseases in the Human Population,” AIDS, Vol. 26, No. 6, 2012, pp. 659-673. doi:10.1097/QAD.0b013e328350fb68
[82] B. Korber, M. Muldoon, J. Theiler, F. Gao, R. Gupta, A. Lapedes, et al., “Timing the Ancestor of the HIV-1 Pandemic Strains,” Science, Vol. 288, No. 5472, 2000, pp. 1789-1796. doi:10.1126/science.288.5472.1789
[83] H. X. Liao, L. L. Sutherland, S. M. Xia, M. E. Brock, R. M. Scearce, S. Vanleeuwen, et al., “A Group M Consensus Envelope Glycoprotein Induces Antibodies that Neutralize Subsets of Subtype B and C HIV-1 Primary Viruses,” Virology, Vol. 353, No. 2, 2006, pp. 268-282. doi:10.1016/j.virol.2006.04.043
[84] T. Zhu, B. T. Korber, A. J. Nahmias, E. Hooper, P. M. Sharp and D. D. Ho, “An African HIV-1 Sequence from 1959 and Implications for the Origin of the Epidemic,” Nature, Vol. 391, No. 6667, 1998, pp. 594-597.
[85] D. L. Robertson, J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser, et al., “HIV-1 Nomenclature Proposal,” Science, Vol. 288, No. 5463, 2000, pp. 55-56. doi:10.1126/science.288.5463.55d
[86] J. C. Plantier, M. Leoz, J. E. Dickerson, F. De Oliveira, F. Cordonnier, V. Lemee, et al., “A New Human Immunodeficiency Virus Derived from Gorillas,” Nature Medicine, Vol. 15, No. 8, 2009, pp. 871-872.
[87] J. Takehisa, M. H. Kraus, A. Ayouba, E. Bailes, H. F. Van, J. M. Decker, et al., “Origin and Biology of Simian Immunodeficiency Virus in Wild-Living Western Gorillas,” Journal of Virology, Vol. 83, No. 4, 2009, pp. 1635-1648. doi:10.1128/JVI.02311-08
[88] A. Vallari, V. Holzmayer, B. Harris, J. Yamaguchi, C. Ngansop, F. Makamche, et al., “Confirmation of Putative HIV-1 Group P in Cameroon,” Journal of Virology, Vol. 85, No. 3, 2011, pp. 1403-1407. doi:10.1128/JVI.02005-10
[89] M. O. Salminen, C. Koch, E. Sanders-Buell, P. K. Ehrenberg, N. L. Michael, J. K. Carr, et al., “Recovery of Virtually Full-Length HIV-1 Provirus of Diverse Subtypes from Primary Virus Cultures Using the Polymerase Chain Reaction,” Virology, Vol. 213, No. 1, 1995, pp. 80-86. doi:10.1006/viro.1995.1548
[90] J. Hemelaar, E. Gouws, P. D. Ghys and S. Osmanov, “Global and Regional Distribution of HIV-1 Genetic Subtypes and Recombinants in 2004,” AIDS, Vol. 20, No. 16, 2006, pp. W13-W23. doi:10.1097/01.aids.0000247564.73009.bc
[91] T. D. Mastro, C. Kunanusont, T. J. Dondero and C. Wasi, “Why Do HIV-1 Subtypes Segregate among Persons with Different Risk Behaviors in South Africa and Thailand?” AIDS, Vol. 11, No. 1, 1997, pp. 113-116. doi:10.1097/00002030-199701000-00017
[92] H. J. Van, R. Wood, M. Lambrick, E. P. Rybicki, A. L. Williamson and C. Williamson, “An Association between HIV-1 Subtypes and Mode of Transmission in Cape Town, South Africa,” AIDS, Vol. 11, No. 1, 1997, pp. 81-87. doi:10.1097/00002030-199701000-00012
[93] J. Louwagie, F. McCutchan, G. van der Groen, M. Peeters, K. Fransen, P. Piot, et al., “Genetic Comparison of HIV-1 Isolates from Africa, Europe, and North America,” AIDS Research and Human Retroviruses, Vol. 8, No. 8, 1992, pp. 1467-1469.
[94] K. Triques, A. Bourgeois, N. Vidal, E. Mpoudi-Ngole, C. Mulanga-Kabeya, N. Nzilambi, et al., “Near-Full-Length Genome Sequencing of Divergent African HIV Type 1 Subtype F Viruses Leads to the Identification of a New HIV Type 1 Subtype Designated K,” AIDS Research and Human Retroviruses, Vol. 16, No. 2, 2000, pp. 139-151. doi:10.1089/088922200309485
[95] S. T. Meloni, B. Kim, J. L. Sankale, D. J. Hamel, S. Tovanabutra, S. Mboup, et al., “Distinct Human Immunodeficiency Virus Type 1 Subtype A Virus Circulating in West Africa: Sub-Subtype A3,” Journal of Virology, Vol. 78, No. 22, 2004, pp. 12438-12445. doi:10.1128/JVI.78.22.12438-12445.2004
[96] J. K. Carr, M. O. Salminen, J. Albert, E. Sanders-Buell, D. Gotte, D. L. Birx, et al., “Full Genome Sequences of Human Immunodeficiency Virus Type 1 Subtypes G and A/G Intersubtype Recombinants,” Virology, Vol. 247, No. 1, 1998, pp. 22-31. doi:10.1006/viro.1998.9211
[97] M. M. Thomson and R. Najera, “Molecular Epidemiology of HIV-1 Variants in the Global AIDS Pandemic: An Update,” AIDS Reviews, Vol. 7, No. 4, 2005, pp. 210-224.
[98] F. Gao, D. L. Robertson, S. G. Morrison, H. Hui, S. Craig, J. Decker, et al., “The Heterosexual Human Immunodeficiency Virus Type 1 Epidemic in Thailand Is Caused by an Intersubtype (A/E) Recombinant of African Origin,” Journal of Virology, Vol. 70, No. 10, 1996, pp. 7013-7029.
[99] G. Casado, M. M. Thomson, M. Sierra and R. Najera, “Identification of a Novel HIV-1 Circulating ADG Intersubtype Recombinant Form (CRF19_cpx) in Cuba,” Journal of Acquired Immune Deficiency Syndromes, Vol. 40, No. 5, 2005, pp. 532-537. doi:10.1097/01.qai.0000186363.27587.c0
[100] J. Hemelaar, E. Gouws, P. D. Ghys and S. Osmanov, “Global and Regional Distribution of HIV-1 Genetic Subtypes and Recombinants in 2004,” AIDS, Vol. 20, No. 16, 2006, pp. W13-W23. doi:10.1097/01.aids.0000247564.73009.bc
[101] J. R. Neilson, G. C. John, J. K. Carr, P. Lewis, J. K. Kreiss, S. Jackson, et al., “Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, Kenya,” Journal of Virology, Vol. 73, No. 5, 1999, pp. 4393-4403.
[102] M. A. Montano, C. P. Nixon, T. Ndung'u, H. Bussmann, V. A. Novitsky, D. Dickman, et al., “Elevated Tumor Necrosis Factor-alpha Activation of Human Immunodeficiency Virus Type 1 Subtype C in Southern Africa Is Associated with an NF-kappaB Enhancer Gain-Of-Function,” The Journal of Infectious Diseases, Vol. 181, No. 1, 2000, pp. 76-81.doi:10.1086/315185
[103] J. T. Blackard, B. Renjifo, W. Fawzi, E. Hertzmark, G. Msamanga, D. Mwakagile, et al., “HIV-1 LTR Subtype and Perinatal Transmission,” Virology, Vol. 287, No. 2, 2001, pp. 261-265. doi:10.1006/viro.2001.1059
[104] B. Renjifo, W. Fawzi, D. Mwakagile, D. Hunter, G. Msamanga, D. Spiegelman, et al., “Differences in Perinatal Transmission among Human Immunodeficiency Virus Type 1 Genotypes,” Journal of Human Virology, Vol. 4, No. 1, 2001, pp. 16-25.
[105] G. N. Odaibo, E. Donbraye, M. O. Adewumi, A. S. Bakarey, M. A. Ibeh and D. O. Olaleye, “Reliability of Testing and Potential Impact on HIV Prevention in Nigeria,” African Journal of Medicine and Medical Sciences, Vol. 35, 2006, pp. S131-S135.
[106] G. Nabel, W. Makgoba and J. Esparza, “HIV-1 Diversity and Vaccine Development,” Science, Vol. 296, No. 5577, 2002, p. 2335. doi:10.1126/science.296.5577.2335
[107] J. M. Coffin, “HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy,” Science, Vol. 267, No. 5197, 1995, pp. 483-489. doi:10.1126/science.7824947
[108] Y. Shao and C. Williamson, “The HIV-1 Epidemic: Low-to Middle-Income Countries,” Cold Spring Harbor Perspectives in Medicine, Vol. 2, No. 3, 2012, Article ID: A007187. doi:10.1101/cshperspect.a007187
[109] J. Hemelaar, E. Gouws, P. D. Ghys and S. Osmanov, “Global Trends in Molecular Epidemiology of HIV-1 during 2000-2007,” AIDS, Vol. 25, No. 5, 2011, pp. 679-689. doi:10.1097/QAD.0b013e328342ff93
[110] M. Batra, P. C. Tien, R. W. Shafer, C. H. Contag and D. A. Katzenstein, “HIV Type 1 Envelope Subtype C Sequences from Recent Seroconverters in Zimbabwe,” AIDS Research and Human Retroviruses, Vol. 16, No. 10, 2000, pp. 973-979. doi:10.1089/08892220050058399
[111] P. C. Tien, T. Chiu, A. Latif, S. Ray, M. Batra, C. H. Contag, et al., “Primary Subtype C HIV-1 Infection in Harare, Zimbabwe,” Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, Vol. 20, No. 2, 1999, pp. 147-153. doi:10.1097/00042560-199902010-00006
[112] H. Guevara, E. Johnston, L. Zijenah, O. Tobaiwa, P. Mason, C. Contag, et al., “Prenatal Transmission of Subtype C HIV-1 in Zimbabwe: HIV-1 RNA and DNA in Maternal and Cord Blood,” Journal of Acquired Immune Deficiency Syndromes, Vol. 25, No. 5, 2000, pp. 390-397. doi:10.1097/00126334-200012150-00002
[113] S. C. Dalai, T. De Oliveira, G. W. Harkins, S. G. Kassaye, J. Lint, J. Manasa, et al., “Evolution and Molecular Epidemiology of Subtype C HIV-1 in Zimbabwe,” AIDS, Vol. 23, No. 18, 2009, pp. 2523-2532. doi:10.1097/QAD.0b013e3283320ef3
[114] B. L. Walter, A. E. Armitage, S. C. Graham, T. De Oliveira, P. Skinhoj, E. Y. Jones, et al., “Functional Characteristics of HIV-1 Subtype C Compatible with Increased Heterosexual Transmissibility,” AIDS, Vol. 23, No. 9, 2009, pp. 1047-1057. doi:10.1097/QAD.0b013e32832a1806
[115] T. Ndung'u, Y. Lu, B. Renjifo, N. Touzjian, N. Kushner, V. Pena-Cruz, et al., “Infectious Simian/Human Immunodeficiency Virus with Human Immunodeficiency Virus Type 1 Subtype C from an African Isolate: Rhesus Macaque Model,” Journal of Virology, Vol. 75, No. 23, 2001, pp. 11417-11425. doi:10.1128/JVI.75.23.11417-11425.2001
[116] S. Osmanov, C. Pattou, N. Walker, B. Schwardlander and J. Esparza, “Estimated Global Distribution and Regional Spread of HIV-1 Genetic Subtypes in the Year 2000,” Journal of Acquired Immune Deficiency Syndromes, Vol. 29, No. 2, 2002, pp. 184-190.
[117] P. Gupta, K. B. Collins, D. Ratner, S. Watkins, G. J. Naus, D. V. Landers, et al., “Memory CD4+ T Cells Are the Earliest Detectable Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Cells in the Female Genital Mucosal Tissue during HIV-1 Transmission in an Organ Culture System,” Journal of Virology, Vol. 76, No. 19, 2002, pp. 9868-9876. doi:10.1128/JVI.76.19.9868-9876.2002
[118] J. T. Herbeck, D. C. Nickle, G. H. Learn, G. S. Gottlieb, M. E. Curlin, L. Heath, et al., “Human Immunodeficiency Virus Type 1 env Evolves toward Ancestral States upon Transmission to a New Host,” Journal of Virology, Vol. 80, No. 4, 2006, pp. 1637-1644. doi:10.1128/JVI.80.4.1637-1644.2006
[119] M. Sagar, O. Laeyendecker, S. Lee, J. Gamiel, M. J. Wawer, R. H. Gray, et al., “Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission,” The Journal of Infectious Diseases, Vol. 199, No. 4, 2009, pp. 580-589. doi:10.1086/596557
[120] S. H. Eshleman, Y. Lie, D. R. Hoover, S. Chen, S. E. Hudelson, S. A. Fiscus, et al., “Association between the Replication Capacity and Mother-to-Child Transmission of HIV-1, in Antiretroviral Drug-Naive Malawian Women,” The Journal of Infectious Diseases, Vol. 193, No. 11, 2006, pp. 1512-1515. doi:10.1086/503810
[121] J. R. Lingappa, J. P. Hughes, R. S. Wang, J. M. Baeten, C. Celum, G. E. Gray, et al., “Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk,” PLoS One, Vol. 5, No. 9, 2010, e12598. doi:10.1371/journal.pone.0012598
[122] M. Essex, L. E. Soto-Ramirez, E. Renjifo, W. K. Wang, T. H. Lee, “Genetic Variation within Human Immunodeficiency Viruses Generates Rapid Changes in Tropism, Virulence, and Transmission,” Leukemia, Vol. 11, Suppl. 3, 1997, pp. 93-94.
[123] N. Kiwanuka, O. Laeyendecker, T. C. Quinn, M. J. Wawer, J. Shepherd, M. Robb, et al., “HIV-1 Subtypes and Differences in Heterosexual HIV Transmission among HIV-Discordant Couples in Rakai, Uganda,” AIDS, Vol. 23, No. 18, 2009, pp. 2479-2484. doi:10.1097/QAD.0b013e328330cc08
[124] B. L. Guthrie, G. de Bruyn and C. Farquhar, “HIV-1-Discordant Couples in Sub-Saharan Africa: Explanations and Implications for High Rates of Discordancy,” Current HIV Research, Vol. 5, No. 4, 2007, pp. 416-429. doi:10.2174/157016207781023992
[125] P. R. Mehta, S. Nema, S. Paranjpe, N. Ingole, S. Wanjare and G. Nataraj, “Study of HIV-1 Subtypes in Serodiscordant Couples Attending an Integrated Counselling and Testing Centre in Mumbai Using Heteroduplex Mobility Analysis and DNA Sequencing,” Indian Journal of Medical Microbiology, Vol. 28, No. 4, 2010, pp. 290-294. doi:10.4103/0255-0857.71807
[126] R. M. Troyer, K. R. Collins, A. Abraha, E. Fraundorf, D. M. Moore, R. W. Krizan, et al., “Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression,” Journal of Virology, Vol. 79, No. 14, 2005, pp. 9006-9018. doi:10.1128/JVI.79.14.9006-9018.2005
[127] D. Archary, M. L. Gordon, T. N. Green, H. M. Coovadia, P. J. Goulder and T. Ndung'u, “HIV-1 Subtype C Envelope Characteristics Associated with Divergent Rates of Chronic Disease Progression,” Retrovirology, Vol. 7, 2010, p. 92. doi:10.1186/1742-4690-7-92
[128] P. J. Kanki, D. J. Hamel, J. L. Sankale, C. Hsieh, I. Thior, F. Barin, et al., “Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression,” The Journal of Infectious Diseases, Vol. 179, No. 1, 1999, pp. 68-73. doi:10.1086/314557
[129] A. Vasan, B. Renjifo, E. Hertzmark, B. Chaplin, G. Msamanga, M. Essex, et al., “Different Rates of Disease Progression of HIV Type 1 Infection in Tanzania Based on Infecting Subtype,” Clinical Infectious Diseases, Vol. 42, No. 6, 2006, pp. 843-852. doi:10.1086/499952
[130] P. Kaleebu, N. French, C. Mahe, D. Yirrell, C. Watera, F. Lyagoba, et al., “Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV-1—Positive Persons in Uganda,” The Journal of Infectious Diseases, Vol. 185, No. 9, 2002, pp. 1244-1250. doi:10.1086/340130
[131] N. Kiwanuka, O. Laeyendecker, M. Robb, G. Kigozi, M. Arroyo, F. McCutchan, et al., “Effect of Human Immunodeficiency Virus Type 1 (HIV-1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV-1 Infection,” The Journal of Infectious Diseases, Vol. 197, No. 5, 2008, pp. 707-713. doi:10.1086/527416
[132] N. R. Mugo, M. Med, R. Heffron, D. Donnell, A. Wald, E. O. Were, et al., “Increased Risk of HIV-1 Transmission in Pregnancy: A Prospective Study among African HIV-1 Serodiscordant Couples,” AIDS, Vol. 25, No. 15, 2011, pp. 1887-1895. doi:10.1097/QAD.0b013e32834a9338
[133] G. C. John-Stewart, R. W. Nduati, C. M. Rousseau, D. A. Mbori-Ngacha, B. A. Richardson, S. Rainwater, et al., “Subtype C Is Associated with Increased Vaginal Shedding of HIV-1,” The Journal of Infectious Diseases, Vol. 192, No. 3, 2005, pp. 492-496. doi:10.1086/431514
[134] L. A. Panther, L. Tucker, C. Xu, R. E. Tuomala, J. I. Mullins and D. J. Anderson, “Genital Tract Human Immunodeficiency Virus Type 1 (HIV-1) Shedding and Inflammation and HIV-1 env Diversity in Perinatal HIV-1 Transmission,” The Journal of Infectious Diseases, Vol. 181, No. 2, 2000, pp. 555-563. doi:10.1086/315230
[135] E. L. Delwart, E. G. Shpaer, J. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen-Waigmann, et al., “Genetic Relationships Determined by a DNA Heteroduplex Mobility Assay: Analysis of HIV-1 env Genes,” Science, Vol. 262, No. 5137, 1993, pp. 1257-1261. doi:10.1126/science.8235655
[136] L. Heyndrickx, W. Janssens, L. Zekeng, R. Musonda, S. Anagonou, G. Van der Auwera, et al., “Simplified Strategy for Detection of Recombinant Human Immunodeficiency Virus Type 1 Group M Isolates by gag/env Heteroduplex Mobility Assay. Study Group on Heterogeneity of HIV Epidemics in African Cities,” Journal of Virology, Vol. 74, No. 1, 2000, pp. 363-370. doi:10.1128/JVI.74.1.363-370.2000

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.